Portfolio company
Nearwave
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nearwave develops handheld, non-invasive near-infrared imaging devices to help oncologists and clinical researchers monitor breast cancer treatment efficacy and assess deep tissue biomarkers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deep Light Vision
This company develops quantum-enabled ultrasound optical tomography imaging devices for clinicians to diagnose breast cancer and monitor neonatal health.
MammoCheck
This company develops a thermal camera and mobile application that uses artificial intelligence to provide at-home breast cancer screening for women.
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Openwater
Openwater develops portable medical devices using light and ultrasound to diagnose and treat diseases like cancer and depression for healthcare providers and researchers.
BioPatch
BioPatch develops a non-invasive adhesive patch for breast cancer detection using electrical conductivity measurements for healthcare providers and patients.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
